Baird Maintains Neutral on Medtronic, Raises Price Target to $100
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsPrice TargetHot
Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $91 to $100.
Baird analyst David Rescott maintains Medtronic (NYSE:MDT) with a Neutral and raises the price target from $91 to $100.